AZ Halts Epanova Study As High Placebo Effect Kills Acasti’s Omega-3 TRILOGY-1 Trial
AZ’s Epanova Hopes Dented, Acasti Focus Turns To Coming TRILOGY-2 Results
• By Sten Stovall
Derived from krill oil, Acasti’s CaPre is aimed at treating hypertriglyceridemia • Source: Shutterstock 
